Upgrade to SI Premium - Free Trial

Protalix BioTherapeutics (PLX)

2.69 +0.08 (3.07%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/16/26)

Latest Headlines

Protalix BioTherapeutics to Announce Third Quarter 2026 Financial Results and Business Update on November 10, 2026 November 3, 2026 6:50 AM - PR NewsWire Protalix BioTherapeutics to Present at the Stifel 2026 Healthcare Conference October 26, 2026 6:50 AM - PR NewsWire Form SCHEDULE 13G Protalix BioTherapeutics Filed by: HOLD Alapkezelo Zrt. October 15, 2026 8:49 AM - SEC Filing Form 4 Protalix BioTherapeutics For: Sep 03 Filed by: Schwartz Aharon September 9, 2026 5:01 PM - SEC Filing Protalix BioTherapeutics to Participate in Upcoming September 2026 Investor Conferences September 8, 2026 6:45 AM - PR NewsWire Form 4 Protalix BioTherapeutics For: Sep 03 Filed by: Elze Christian September 4, 2026 6:07 AM - SEC Filing Form 4 Protalix BioTherapeutics For: Sep 03 Filed by: Boudes Pol F September 4, 2026 6:07 AM - SEC Filing Form 4 Protalix BioTherapeutics For: Sep 03 Filed by: Bashan Dror September 4, 2026 6:07 AM - SEC Filing Form 4 Protalix BioTherapeutics For: Sep 03 Filed by: Ben Zvi Shmuel September 4, 2026 6:07 AM - SEC Filing Form 4 Protalix BioTherapeutics For: Sep 03 Filed by: Melincoff Gwen A September 4, 2026 6:07 AM - SEC Filing Form 4 Protalix BioTherapeutics For: Sep 03 Filed by: Naos Yaron September 4, 2026 6:07 AM - SEC Filing Form 4 Protalix BioTherapeutics For: Sep 03 Filed by: Forster Eliot September 4, 2026 6:07 AM - SEC Filing Form 4 Protalix BioTherapeutics For: Sep 03 Filed by: Bar-Shalev Amos September 4, 2026 6:06 AM - SEC Filing Form S-8 Protalix BioTherapeutics August 12, 2026 7:41 AM - SEC Filing Form 10-Q Protalix BioTherapeutics For: Jun 30 August 12, 2026 7:10 AM - SEC Filing Form 8-K Protalix BioTherapeutics For: Aug 12 August 12, 2026 7:00 AM - SEC Filing Protalix BioTherapeutics Reports Second Quarter 2026 Financial and Business Results August 12, 2026 6:50 AM - PR NewsWire Full Article List